-+ 0.00%
-+ 0.00%
-+ 0.00%

Gene One Life Science Rejects Former CEO’s USD 174 Million Damages Claim

PUBT·11/16/2026 07:52:49
Listen to the news
Gene One Life Science Rejects Former CEO’s USD 174 Million Damages Claim
  • Gene One Life Science amended its first-quarter 2026 report on November 16 to disclose a USD 174 million lawsuit by former CEO Young K. Park.
  • The suit, disclosed August 4, alleges defamation and breaches of a retirement agreement involving the company and subsidiary VGXI.
  • Defendants sought dismissal in federal court, citing lack of personal jurisdiction and improper service.
  • Formal service remained incomplete; the company rejected the allegations, defending its communications as legitimate corporate notices containing no false statements.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261116000794), on November 16, 2026, and is solely responsible for the information contained therein.